Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® Toric

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To allow surgeons to obtain clinical experience on the postoperative uncorrected and best distance corrected visual acuities (UCVA and BDCVA) and corneal and refractive cylinder of the AcrySof Toric IOL.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens

NCT00760487

Cataract

COMPLETED PHASE4

Rotational Stability of the AcrySof® Toric

NCT00762216

Cataract

COMPLETED NA

Comparison of Corneal Aberrations and Visual Outcomes in AcrySof IQ Toric Patients Versus Limbal Relaxing Incision (LRI) Patients

NCT00929747

Cataracts

WITHDRAWN PHASE4

AcrySof Toric Clinical Results

NCT01214863

Cataracts Astigmatism

COMPLETED

Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses

NCT06541795

Aphakia Presbyopia Residual Refractive Cylinder

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

AcrySof® Toric IOL

Group Type EXPERIMENTAL

AcrySof® Toric IOL

Intervention Type DEVICE

Implanted into the study eye

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AcrySof® Toric IOL

Implanted into the study eye

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 40-80 years old; of any race and gender; diagnosed with bilateral cataracts; require cataract extraction followed by implantation of a posterior chamber IOL; patients have between 0.75 -2.5 D of astigmatism preoperatively as measured by K readings.

Exclusion Criteria

* Females of child bearing potential;irregular corneal astigmatism;keratopathy/Keratectasia; cornea inflammation or edema;previous corneal reshaping,dystrophy or transplant;amblyopia;glaucoma;RPE/Macular changes;diabetic retinopathy.

Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No